Wealth Enhancement Advisory Services’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25K Sell
17,235
-11,993
-41% -$23.4K ﹤0.01% 4106
2026
Q2
$33.2K Buy
+29,228
New +$57.5K ﹤0.01% 3977

Other funds holding PALI

Wealth Enhancement Advisory Services's PALI Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Palisade Bio (PALI) stake by 41% in Q3 2026, selling an estimated $23.4K and leaving 17,235 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.

Wealth Enhancement Advisory Services first reported a position in PALI in Q2 2026 and has held it in 2 quarters since. The position peaked at $33.2K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Wealth Enhancement Advisory Services held 17,235 shares of Palisade Bio worth $25K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 11,993 Palisade Bio shares in Q3 2026, an estimated $23.4K.
  • Palisade Bio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4106 holding.
  • Wealth Enhancement Advisory Services first reported a position in Palisade Bio in Q2 2026 and has held it in 2 quarters since.
  • Wealth Enhancement Advisory Services's Palisade Bio position peaked at $33.2K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.